Effectiveness and Safety of Fluticasone Propionate in Adolescents and Adults Who Have Asthma

Study Title
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Teva Identifier
FpS-AS-202 | 2010-023601-35
ClinicalTrials.gov Identifier
NCT01576718
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Fp MDPI | Other: Placebo MDPI | Drug: Flovent Diskus | Drug: albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
04/01/2012 - 10/01/2013
Phase
Phase 2

Study Type

Interventional